• Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastoma
  • Sustained CD4<sup>+</sup> T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide
  • Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy
  • Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo

 Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastoma

Justyna Kmiecik, Andrea Gras Navarro, Aurelie Poli, Jesús Planagumà Planagumà, Jacques Zimmer and Martha Chekenya

View Article

 Sustained CD4+ T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide

Susannah Ellsworth, Ani Balmanoukian, Ferdynand Kos, Christopher J Nirschl, Thomas R Nirschl, Stuart A Grossman, Leo Luznik and Charles G Drake

View Article

Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy

Gautier Stoll, David Enot, Bernhard Mlecnik, Jérôme Galon, Laurence Zitvogel and Guido Kroemer

View Article

 Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo

Linda C Sandin, Fredrik Eriksson, Peter Ellmark, Angelica SI Loskog, Thomas H Tötterman and Sara M Mangsbo

View Article

Explore OncoImmunology

Recent Articles

Editors-in-Chief

Guido Kroemer
University of Paris Descartes
Laurence Zitvogel
INSERM, Institut Gustave Roussy
Lorenzo Galluzzi
Université Paris Descartes/Paris V